VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
GL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
GLGlobe Life Inc.
$157.18$12.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksGLFinancials

Globe Life Inc. (GL) Income Statement

30Y historyFree accessUpdated daily

Revenue growth has moderated to 5.5% in 2026Q3 from 8.6% in 2024Q2, while combined ratios have ranged from 68.5% to 139.4%, indicating earnings highly sensitive to claim timing.

Income StatementBalance SheetCash FlowRatios

GL Income Statement

Annual statement

GL Income Statement

Globe Life Inc. (GL) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue6.28B6B5.78B5.45B5.23B5.12B4.74B4.53B4.31B4.16B3.93B3.77B3.62B3.49B3.59B3.38B3.37B3.12B3.2B3.49B3.42B3.13B3.07B2.93B2.76B2.71B2.52B2.23B2.16B2.07B2.21B
Revenue Growth %5.69%3.82%6.07%4.22%2.06%8.08%4.66%4.93%3.82%5.63%4.48%4.02%3.61%-2.65%6.28%0.29%8.11%-2.54%-8.33%1.92%9.45%1.77%4.79%6.16%2%7.47%13.11%3.2%4.19%-6.11%6.69%
Medical Costs & Claims4.95B3.99B3.91B3.81B3.69B3.43B3.45B3.21B3.07B257.25M2.85B2.7B2.54B2.45B2.54B2.37B2.37B2.17B2.18B2.29B2.24B2.01B1.99B1.91B1.69B1.76B1.61B2.72B2.53B1.25B1.28B
Medical Cost Ratio %78.81%66.6%67.63%69.89%70.51%67.06%72.9%70.85%71.2%6.19%72.37%71.68%70.21%70.03%70.9%70.29%70.24%69.64%68.23%65.78%65.5%64.34%64.88%65.23%61.3%64.88%64.09%122.18%117.32%60.36%57.89%
Gross Profit1.33B2B1.87B1.64B1.54B1.69B1.28B1.32B1.24B3.9B1.09B1.07B1.08B1.05B1.04B1B1B945.76M1.02B1.19B1.18B1.11B1.08B1.02B1.07B950.61M904.48M-493.95M-373.72M820.9M928.9M
Gross Margin %21.19%33.4%32.37%30.11%29.49%32.94%27.1%29.15%28.8%93.81%27.63%28.32%29.79%29.97%29.1%29.71%29.76%30.36%31.77%34.22%34.5%35.66%35.12%34.77%38.7%35.12%35.91%-22.18%-17.32%39.64%42.11%
Gross Profit Growth %-7.14%14.02%6.43%-8.65%31.38%-2.71%6.19%-68.12%258.64%1.91%-1.1%3%0.24%4.12%0.1%5.99%-6.85%-14.91%1.11%5.87%3.35%5.83%-4.63%12.42%5.1%283.11%-32.17%-145.53%-11.63%8.76%
Operating Expenses756.62M540.97M543.62M445.98M439.04M412.39M387.34M388.49M379.16M3.24B314.86M300.5M293.92M291.9M278.69M279.54M251.8M368.68M386.91M396.45M406.59M383.24M357.82M366.1M478.59M349.18M338.62M-896.36M-820.72M55.2M433.77M
OpEx / Revenue %12.05%9.02%9.41%8.19%8.4%8.05%8.17%8.58%8.79%77.96%8%7.98%8.12%8.35%7.76%8.28%7.48%11.84%12.11%11.37%11.88%12.26%11.65%12.49%17.33%12.9%13.44%-40.25%-38.03%2.67%19.66%
Depreciation & Amortization0000000000000000000391.01M377.49M349.96M347.25M4.81M302.73M5.82M6.86M8.84M7.93M8M9.06M
Combined Ratio %90.86%75.62%77.04%78.08%78.91%75.11%81.08%79.43%79.98%84.15%80.37%79.66%78.33%78.38%78.66%78.57%77.71%81.47%80.34%77.15%77.39%76.6%76.53%77.72%78.63%77.78%77.53%81.93%79.29%63.03%77.55%
Operating Income573.81M1.46B1.33B1.19B1.1B1.27B896.68M931.28M863.67M923.93M772.24M766.19M784.68M755.32M765.99M723.78M750.57M577.08M628.4M796.8M773.57M731.52M720.8M653.1M590.05M601.43M565.86M402.41M446.99M765.7M495.13M
Operating Margin %9.14%24.38%22.96%21.92%21.09%24.89%18.92%20.57%20.02%22.23%19.63%20.34%21.67%21.62%21.34%21.43%22.29%18.53%19.66%22.85%22.61%23.4%23.47%22.28%21.37%22.22%22.47%18.07%20.71%36.97%22.45%
Operating Income Growth %-10.26%11.08%8.36%-13.53%42.15%-3.71%7.83%-6.52%19.64%0.79%-2.36%3.89%-1.39%5.83%-3.57%30.06%-8.17%-21.14%3%5.75%1.49%10.37%10.69%-1.89%6.29%40.62%-9.97%-41.62%54.65%15.64%
EBITDA596.82M1.59B1.45B1.3B1.19B1.36B983.39M1.02B953.75M915.18M855.58M842.83M860.8M835.78M846.5M801.69M826.1M647.01M691.63M1.19B1.15B1.08B1.07B657.91M892.78M607.25M572.72M411.25M454.93M773.7M504.19M
EBITDA Margin %9.5%26.54%25.16%23.8%22.82%26.52%20.75%22.43%22.1%22.02%21.74%22.38%23.78%23.92%23.58%23.74%24.53%20.77%21.64%34.07%33.65%34.6%34.77%22.45%32.33%22.43%22.74%18.47%21.08%37.36%22.86%
Interest Expense143.07M141.22M127.09M102.32M90.39M83.49M86.7M84.31M90.08M85M83.34M76.64M76.13M80.46M80.51M77.91M75.53M69.93M63.23M67.56M73.14M60.93M56.49M56.1M28.59M44.51M54.49M52.34M56.33M71.9M73.61M
Non-Operating Income-23.01M-129.02M-127.09M-102.32M-90.39M-83.49M-86.7M-84.31M-90.08M8.75M-83.34M-76.64M-76.13M-80.46M-80.51M-77.91M-75.53M-69.93M-63.23M-67.56M-73.14M-60.93M-56.49M-56.1M-28.59M-44.51M-51.58M-52.34M-56.33M693.8M-73.61M
Pretax Income1.46B1.44B1.33B1.19B1.1B1.27B896.68M931.28M863.67M830.65M772.24M766.19M784.68M755.32M765.99M723.78M750.57M577.08M628.4M796.8M773.57M731.52M720.8M653.1M590.05M601.43M562.96M402.41M446.99M408.7M495.13M
Pretax Margin %23.31%24%22.96%21.92%21.09%24.89%18.92%20.57%20.02%19.99%19.63%20.34%21.67%21.62%21.34%21.43%22.29%18.53%19.66%22.85%22.61%23.4%23.47%22.28%21.37%22.22%22.35%18.07%20.71%19.73%22.45%
Income Tax278.12M278.57M255.88M223.51M207.72M243.5M164.91M170.4M162.16M-627.62M232.65M249.89M256.6M248.11M236.67M226.17M246.47M191.02M198.7M269.27M254.94M236.13M245.08M223M197.04M205.97M190.84M134.32M154.34M138.4M180.62M
Effective Tax Rate %19%19.35%19.29%18.72%18.85%19.1%18.39%18.3%18.78%-75.56%30.13%32.62%32.7%32.85%30.9%31.25%32.84%33.1%31.62%33.79%32.96%32.28%34%34.14%33.39%34.25%33.9%33.38%34.53%33.86%36.48%
Net Income1.19B1.16B1.07B970.75M894.39M1.03B731.77M760.79M701.47M1.45B549.78M527.1M542.94M528.47M529.32M497.16M498.87M404.95M452.26M527.53M518.63M495.39M468.56M430.1M387.28M356.51M362M273.96M244.44M347.6M311.37M
Net Margin %18.88%19.36%18.53%17.82%17.11%20.13%15.44%16.8%16.26%34.99%13.97%14%15%15.12%14.75%14.72%14.81%13%14.15%15.13%15.16%15.85%15.25%14.67%14.03%13.17%14.37%12.3%11.33%16.78%14.12%
Net Income Growth %3.05%8.44%10.3%8.54%-13.26%40.91%-3.81%8.46%-51.76%164.47%4.3%-2.92%2.74%-0.16%6.47%-0.34%23.19%-10.46%-14.27%1.72%4.69%5.73%8.94%11.06%8.63%-1.52%32.14%12.07%-29.68%11.63%117.39%
EPS (Diluted)15.1514.0611.9410.079.047.226.826.836.0812.224.494.164.093.793.603.142.802.172.272.452.282.081.861.661.411.271.250.940.801.080.97
EPS Growth %8.93%17.76%18.57%11.39%25.21%5.87%-0.15%12.34%-50.25%172.16%7.93%1.71%7.92%5.28%14.65%12.14%29.03%-4.41%-7.35%7.46%9.62%11.83%12.05%17.73%11.02%1.6%32.98%17.5%-25.93%11.34%120.45%
EPS (Basic)-14.3011.9910.219.137.306.906.976.2212.504.584.214.153.843.653.192.832.172.282.492.312.101.891.671.421.281.260.950.811.080.97
Diluted Shares Outstanding78.22M80.85M84.75M96.36M98.98M103.17M107.22M111.38M115.25M118.98M122.37M126.76M132.64M139.56M146.85M164.72M184.69M186.83M199.16M215.65M227.47M238.17M251.61M259.44M271.3M279.84M288.83M292.06M305.2M312.69M322.16M

Key Metrics

Growth RegimeMixed
ProfitabilityStrong
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

Unresolved EEOC sales-practice review

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Top-Line Growth Decelerating From Earlier Pace

Based on reported quarterly figures, GL's revenue growth moderated from 8.6% in 2024Q2 to 5.5% in 2026Q3, with the 2026Q3 print on about $1.6B suggesting top-line expansion is slowing as the Medicare Supplement mix shift weighs on volume.

The deceleration in revenue growth suggests the premium base is expanding more slowly than in 2024, which may reflect a combination of agent recruitment constraints and a deliberate pivot toward lower-margin products. Investors should monitor whether growth stabilizes in the mid-single digits or continues to fade, since a persistent slowdown would increase reliance on margin preservation for earnings growth.

Underwriting Results Volatile Quarter to Quarter

As reported in the quarterly income statements, GL's loss ratio ranged from 43.5% in 2026Q3 to 150.3% in 2026Q2, while the combined ratio swung between 68.5% and 139.4%, indicating underwriting results that are highly sensitive to claim timing.

The wide dispersion suggests that periodic claim spikes, rather than a steady underlying trend, drive much of the reported underwriting result, and the 2026Q2 quarter with a combined ratio above 100% implies a reliance on other income that quarter. Excluding the outlier, the typical combined ratio near 70% to 78% appears consistent with underwriting profitability, though the sustainability of the lower 2026Q3 loss ratio warrants further investigation.

Investment Income Contribution Not Disclosed

Investment income and investment yield fields are unavailable in the provided quarterly data, so the contribution of investment returns to GL's reported earnings cannot be quantified from these figures.

Without disclosed investment income, the extent to which net income depends on portfolio yield versus underwriting cannot be assessed directly from the supplied dataset. Analysts should consult the underlying filings for net investment income and realized gains before drawing conclusions about earnings quality.

2026Q2 Quarter Marks Earnings Inflection

According to the reported quarterly figures, GL's 2026Q2 operating income turned negative at roughly -$629.6M on a loss ratio of 150.3%, followed by an EPS rebound to $4.62 in 2026Q3 against a $3.61 consensus estimate.

The 2026Q2 quarter appears to be a discrete loss event rather than a trend, given the immediate recovery in 2026Q3 operating income to $479.0M. The quarter may reflect a concentrated claims or reserve charge, and the absence of disclosed cause in this dataset warrants investigation before treating the rebound as evidence of durable margin recovery.

Quarterly Beat May Reflect Timing

Based on GL's reported 2026Q3 EPS of $4.62 versus a $3.61 consensus, the beat coincides with an unusually low loss ratio of 43.5%, which may reflect favorable claim timing rather than sustainable underwriting improvement.

A single-quarter beat driven by a loss ratio well below the 60% to 70% range seen across most other quarters could reverse in subsequent periods. The unresolved EEOC review and ongoing product-mix transition add uncertainty that the headline beat does not resolve, so investors should weigh the earnings rebound cautiously.

GL — Frequently Asked Questions

Quick answers to the most common questions about buying GL stock.

What was Globe Life Inc.'s (GL) revenue in 2025?

For fiscal year 2025, Globe Life Inc. (GL) reported total revenue of $6.00B. This represents a 171.9% increase compared to $2.21B in 1996.

Is Globe Life Inc. (GL) profitable?

Globe Life Inc. (GL) is profitable, generating $1.16B in net income for the fiscal year ending 2025 with a net profit margin of 19.4%.

What is Globe Life Inc.'s operating profit margin?

Globe Life Inc. (GL) reported an operating income of $1.46B, resulting in an operating profit margin of 24.4%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Globe Life Inc.'s gross profit and gross margin?

Globe Life Inc. (GL) generated $2.00B in gross profit for the year, representing a gross profit margin of 33.4%. This demonstrates the company's core pricing power and production efficiency.